In a groundbreaking discovery, researchers at The University of Texas at Austin have identified an antibody capable of neutralizing all known variants of COVID-19, sparking hope for the development of a universal vaccine and more effective treatments.
The antibody, named SC27, was isolated from a single patient as part of a multi-institutional study led by UT Austin. The research team, which includes engineers, scientists, and medical experts, found that SC27 can neutralize not only COVID-19 variants but also several other coronaviruses found in animals. This discovery opens the door to developing treatments that could protect against future viral threats.
